Navigation Links
Auxilium Pharmaceuticals Announces Results from Three Year CORDLESS Extension Study in Dupuytren's Contracture
Date:6/30/2011

MALVERN, Pa., June 30, 2011 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced three year recurrence data from the Collagenase Optimal Reduction of Dupuytren's - Long-term Evaluation of Success Study (CORDLESS) for XIAFLEX® (collagenase clostridium histolyticum) in the treatment of adult Dupuytren's contracture patients with a palpable cord. This five year observational study was designed to assess the durability of response following treatment with XIAFLEX, as well as long-term safety and progression of disease in patients from earlier Auxilium studies. At three years, the nominal recurrence rate for the 623 joints previously treated successfully with XIAFLEX was 34.8%.

(Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO)

"In my opinion, the recurrence rate seen with XIAFLEX is comparable with or better than other minimally-invasive treatment options.  More importantly, the fingers I have treated with XIAFLEX do not appear to develop scar tissue, as opposed to surgically treated fingers. Scar slows recovery and complicates further treatment," said Dr. Tom Kaplan, of the Indiana Hand to Shoulder Center. "As a result, first-line use of XIAFLEX preserves all of my treatment options for those patients who do recur."

Data from the XIAFLEX Three Year Follow-upAt three years, 34.8% of joints that had achieved clinical success had experienced recurrence.  Of those patients with affected MP joints, 26.6% of joints that had achieved clinical success had recurrence through three years, while 56.4% of PIP joints that had achieved clinical success had recurrence through three years.Recurrence per protocol definition of >20 degrees or medical interventionAll Joints

MP Joints

PIP JointsPatients from all phase III studies (n=950)

1,568

92
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. BioSpecifics Technologies Corp. Announces Auxilium XIAFLEX® Update
4. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
5. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
6. Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference
7. Auxilium Pharmaceuticals Reports Preliminary Fourth Quarter 2010 Net Revenue and Announces 2011 XIAFLEX Revenue Guidance
8. Auxilium Pharmaceuticals to Present at the 2011 Citi Annual Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
10. Auxilium Pharmaceuticals, Inc. Completes Enrollment of XIAFLEX® Phase III Double-Blind Studies for Peyronies Disease
11. Auxilium Pharmaceuticals, Inc. and Asahi Kasei Pharma Corporation Enter Agreement to Develop, Commercialize and Supply XIAFLEX® In Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... , DURHAM, N.C., Sept. 8 ... formally notified Vatea Fund of the company,s achievement of a milestone ... September 1, 2009. The milestone is a Clinical Trial for Oxycyte ... With the achievement of the milestone, the agreement calls for ...
... BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, Inc. ... clinical trial of its norovirus vaccine. The Phase I/II ... nasally-delivered, dry powder vaccine in healthy adults. The study will ... by including a live virus challenge of subjects that have ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3
(Date:5/20/2013)... 2013 The nationwide law firm of Bernstein ... magnetic resonance imaging (MRI) can be used to predict ... patients are experiencing symptoms. According to an article published ... Joint Surgery, MRI detected synovitis (tissue damage) in 68% of ... to mechanical causes, the detection rate was 75%, while MRIs ...
(Date:5/20/2013)... whose mother lived near heavy traffic while pregnant faces ... before the age of 3, a new study suggests. ... of mothers and infants from eastern Massachusetts. All the ... of pregnancy at some point between 1999 and 2002. ... 100 meters (about 110 yards) from a major roadway, ...
(Date:5/20/2013)... is it about toothpaste that transforms the sweet flavor ... solution to that mysterious sensory phenomenon in colorful, ... American Chemical Society,s award-winning Bytesize Science video ... the world,s largest scientific society, explains that the mainstay ... sulfate, or SLS for short. When you brush your ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Join Seva Foundation ... concert at the Palace of Fine Arts Theater ... Uttal , C.C. White and Shimshai, with host Wavy Gravy. ... the world. , Reserved seats are $40 & ... with the artists and a front row seat at the ...
(Date:5/20/2013)... 20, 2013 Cliff Lake Dental Care is pleased ... patient schedules when visiting the dentist office . The change ... life schedule. , Here are the new office hours: Mondays- 8 ... – 8 a.m. to 1 p.m. and 2-5 p.m., Thursdays 7 ... office will be open to take appointments only. Cliff Lake Dental ...
Breaking Medicine News(10 mins):Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2Health News:Memorial Day Kirtan Concert Palace of Fine Arts Theater in San Francisco Featuring: Snatam Kaur, Jai Uttal, C.C. White & Shimshai with host Wavy Gravy,May 27th 7:00 PM 2Health News:Cliff Lake Dental Care Announces Office Hours Change 2
... student committed suicide by shooting herself at her south ... alone at home in the upmarket Hauz Khas area ... official. She is the daughter of Vijendra Rai, additional ... that Mrinalini had used her father's licensed gun. ...
... a respected osteopathic physician and best known founder ... website, http://www.mercola.com, has revealed the// secrets of some ... Splenda, NutraSweet and the FDA May Be Hazardous ... some artificial sweetener industry. You can watch Dr. ...
... NHS Trust at Scarborough and North East Yorkshire which ... Whitby, Ryedale and Bridlington// is presently facing a dilemma. ... an attempt to overcome the severe financial crunch has ... deliveries at home. ,The Trust which is ...
... high-profile detainee at Guantanamo Bay, Cuba, the US government ... could "cause extremely grave damage", the Washington Post reported ... prisons must not be allowed to talk about the ... lawyers, the Post reported.,A lawyer at a firm that ...
... an individual's immune system to control HIV infection appears ... immune-system molecules// called HLA Class I that have been ... protein those molecules display to the T lymphocytes that ... November issue of PLOS Medicine, researchers from the Partners ...
... An instant fine will be levied to patients who behave ... ?80 fines- a trailblazing move by an NHS hospital to ... , ,The Royal Bolton hospital in Greater Manchester ... violent behavior in hospitals. This move is after much deliberation ...
Cached Medicine News:Health News:Genes determine the capacity to fight HIV in early stages 2Health News:Genes determine the capacity to fight HIV in early stages 3
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... Angle Cutting Electrode is a monopolar ... general purpose monopolar electrosurgical generator and ... ACMI rigid, semi-rigid, or flexible ureteroscope ... working channel larger than 3 Fr. ...
... The ACMI USA Series ACN-2 Flexible CystoNephroscope ... It is ideal for office practice. The ... accommodates a full range of operating instruments ... outer diameter, and beveled, UltraGlide covered tip ...
Medicine Products: